Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2008;34(1):17-22.
doi: 10.1007/s12031-007-0012-9. Epub 2007 Apr 17.

Origins and effects of extracellular alpha-synuclein: implications in Parkinson's disease

Affiliations
Review

Origins and effects of extracellular alpha-synuclein: implications in Parkinson's disease

Seung-Jae Lee. J Mol Neurosci. 2008.

Abstract

Misfolding and abnormal aggregation of the neuronal protein alpha-synuclein has been implicated in the pathogenesis of Parkinson's disease and related neurological disorders, such as dementia with Lewy bodies. alpha-synuclein is a conventional cytosolic protein and is thought to exert its pathogenic function exclusively in the neuronal cytoplasm in a cell-autonomous manner. However, the current model is being challenged by a series of new observations that demonstrate the presence of alpha-synuclein and its aggregated forms in the extracellular fluid both in vivo and in vitro. Extracellular alpha-synuclein appears to be delivered by unconventional exocytosis of intravesicular alpha-synuclein, although the exact mechanism has not been characterized. Compared to the cytosolic alpha-synuclein, intravesicular alpha-synuclein is prone to aggregation and the potential source of extracellular aggregates. A number of tissue culture studies suggest that exposure to extracellular alpha-synuclein aggregates induces microglial activation, release of pro-inflammatory cytokines from astrocytes, and neurotoxicity. Thus, exocytosis of alpha-synuclein may be an important mechanism for amplifying and spreading degenerative changes from a small group of cells to its surrounding tissues, and it potentially provides therapeutic targets for halting the progression of the disease.

PubMed Disclaimer

Similar articles

Cited by

References

    1. Biochem Biophys Res Commun. 2006 Oct 13;349(1):162-6 - PubMed
    1. FASEB J. 2003 Oct;17(13):1945-7 - PubMed
    1. Neuron. 2005 Jun 16;46(6):857-68 - PubMed
    1. Biochemistry. 2003 Jul 8;42(26):7871-8 - PubMed
    1. J Neural Transm (Vienna). 2006 Oct;113(10):1435-9 - PubMed

Publication types

Substances

LinkOut - more resources